Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain ; volume:15 ; number:1 ; day:24 ; month:12 ; year:2015 ; pages:1-13 ; date:12.2015
BMC cancer ; 15, Heft 1 (24.12.2015), 1-13, 12.2015
- Creator
-
Lee, Se Jeong
- Contributor
-
Kang, Won Young
Yoon, Yeup
Jin, Ju Youn
Song, Hye Jin
Her, Jung Hyun
Kang, Sang Mi
Hwang, Yu Kyeong
Kang, Kyeong Jin
Joo, Kyeung Min
Nam, Do-Hyun
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-2034-y
- URN
-
urn:nbn:de:1111-2016110619710
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Se Jeong
- Kang, Won Young
- Yoon, Yeup
- Jin, Ju Youn
- Song, Hye Jin
- Her, Jung Hyun
- Kang, Sang Mi
- Hwang, Yu Kyeong
- Kang, Kyeong Jin
- Joo, Kyeung Min
- Nam, Do-Hyun
- SpringerLink (Online service)
Other Objects (12)
Esophageal natural killer (NK)/T cell lymphoma of true natural killer cell origin
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas
NK cells from RAG- or DCLRE1C-deficient patients inhibit HCMV
Selection and expansion of natural killer cells for NK cell-based immunotherapy
TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells
Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy
Natural killer cell line NK-92-mediated damage of medically important fungi
NK cell regulation
Esophageal natural killer (NK)/T cell lymphoma of true natural killer cell origin
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas
NK cells from RAG- or DCLRE1C-deficient patients inhibit HCMV
Selection and expansion of natural killer cells for NK cell-based immunotherapy
TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells
Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy
Natural killer cell line NK-92-mediated damage of medically important fungi
NK cell regulation
Esophageal natural killer (NK)/T cell lymphoma of true natural killer cell origin
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas
NK cells from RAG- or DCLRE1C-deficient patients inhibit HCMV
Selection and expansion of natural killer cells for NK cell-based immunotherapy
TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells
Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy
Natural killer cell line NK-92-mediated damage of medically important fungi